Ara
Toplam kayıt 2, listelenen: 1-2
Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
(Dove Medical Press Ltd, 2013)
Background: Second generation antipsychotics (SGAs) are currently the most prescribed drugs in the treatment of schizophrenia. Despite their advantages, which include greater improvement in negative symptoms, cognitive ...
Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome
(Dove Medical Press Ltd, 2015)
Background: Brain-derived neurotrophic factor (BDNF) is a well-established neurotrophin that plays a role in the pathophysiology of numerous psychiatric disorders. Many studies have investigated the serum BDNF levels in ...